Funding Received
$22.2 Million in 4 Rounds from 5 Investors
Most Recent Funding
$4.5 Million Private Equity on September 17, 2014
Headquarters:
Yavneh
Description:
Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.
Categories:
Biotechnology
Website:
http://www.avphar.com

Company Details

Update

Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.

Current Team (1)

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • Office

    42 Hayarkon st.

    Northern Industrial Zone

    Yavneh, 81227

    ISR

Images (1)

Update
  • Hqhwnohk5qa1zyifyhau